143 related articles for article (PubMed ID: 6690004)
1. A prospective study of the changes in immune status following radiotherapy for Hodgkin's disease.
van Rijswijk RE; Sybesma JP; Kater L
Cancer; 1984 Jan; 53(1):62-9. PubMed ID: 6690004
[TBL] [Abstract][Full Text] [Related]
2. A prospective study of the changes in the immune status before, during, and after multiple-agent chemotherapy for Hodgkin's disease.
Van Rijswijk RE; Sybesma JP; Kater L
Cancer; 1983 Feb; 51(4):637-44. PubMed ID: 6821837
[TBL] [Abstract][Full Text] [Related]
3. Five-year survival in Hodgkin's disease. The prospective value of immune status at diagnosis.
van Rijswijk RE; de Meijer A; Sybesma JP; Kater L
Cancer; 1986 Apr; 57(8):1489-96. PubMed ID: 2936444
[TBL] [Abstract][Full Text] [Related]
4. The influence of splenectomy on cellular immunologic parameters in Hodgkin's disease.
Wagener DJ; Geestman E; Borgonjen A; Haanen C
Cancer; 1976 May; 37(5):2212-9. PubMed ID: 130968
[TBL] [Abstract][Full Text] [Related]
5. Long-term influence of splenectomy on immune functions in patients with Hodgkin's disease.
Björkholm M; Askergren J; Holm G; Mellstedt H
Scand J Haematol; 1980 Jan; 24(1):87-94. PubMed ID: 6966069
[TBL] [Abstract][Full Text] [Related]
6. Lymphocyte subpopulations in Hodgkin's disease and non-Hodgkin's lymphoma and the effects of radiotherapy.
Balasem AN; Barker CR
Clin Radiol; 1984 Sep; 35(5):353-7. PubMed ID: 6236011
[TBL] [Abstract][Full Text] [Related]
7. B and T lymphocytes in Hodgkin's disease. Analysis at diagnosis and following therapy.
Gajl-Peczalska KJ; Bloomfield CD; Sosin H; Kersey JH
Clin Exp Immunol; 1976 Jan; 23(1):47-55. PubMed ID: 1083318
[TBL] [Abstract][Full Text] [Related]
8. Changes in immune status in patients undergoing splenectomy for the staging of Hodgkin's disease.
Hancock BW; Bruce L; Ward AM; Richmond J
Br Med J; 1976 Feb; 1(6005):313-5. PubMed ID: 1247837
[TBL] [Abstract][Full Text] [Related]
9. Influence of splenectomy upon immunologic reactivity of patients with Hodgkin's disease.
Rogan-Grgas J; Milas L; Hauptmann E; Nola P; Kolarić K; Maricić Z; Malenica B
Tumori; 1981 Dec; 67(6):539-47. PubMed ID: 6977906
[TBL] [Abstract][Full Text] [Related]
10. [Proportions and absolute count of T- and B-lymphocytes in peripheral blood and their blastic transformation induced by mitogens in splenectomized and non-splenectomized patients with Hodgkin's disease].
Pluzańska A
Acta Haematol Pol; 1978; 9(1):37-44. PubMed ID: 307325
[TBL] [Abstract][Full Text] [Related]
11. The influence of splenectomy on the invitro lymphocyte response to phytohemagglutinin and pokeweed mitogen in Hodgkin's disease.
Wagener DJ; Geestman E; Wessels HM
Cancer; 1975 Jul; 36(1):194-8. PubMed ID: 1203846
[TBL] [Abstract][Full Text] [Related]
12. Immunologic impairment after long-term remission in splenectomized patients with Hodgkin's disease.
Loven D; Pick AI; Weiss H; Duczyminer-Kahana M; Lurie H
Acta Oncol; 1991; 30(6):763-5. PubMed ID: 1958399
[No Abstract] [Full Text] [Related]
13. Effects of radiochemotherapy and splenectomy on cellular immunity in long-term survivors of Hodgkin's disease and non-Hodgkin's lymphoma.
Steele R; Han T
Cancer; 1978 Jul; 42(1):133-9. PubMed ID: 667791
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal studies of blood lymphocyte capacity in Hodgkin's disease.
Björkholm M; Wedelin C; Holm G; Johansson B; Mellstedt H
Cancer; 1981 Nov; 48(9):2010-5. PubMed ID: 7296509
[TBL] [Abstract][Full Text] [Related]
15. Abnormalities of in vitro immunoglobulin synthesis by peripheral blood lymphocytes from untreated patients with Hodgkin's disease.
Romagnani S; Del Prete GF; Maggi E; Bellesi G; Biti G; Rossi Ferrini PL; Ricci M
J Clin Invest; 1983 May; 71(5):1375-82. PubMed ID: 6602150
[TBL] [Abstract][Full Text] [Related]
16. B lymphocytes in untreated patients with malignant lymphoma and Hodgkin's disease.
Gajl-Peczalska KJ; Hansen JA; Bloomfield CD; Good RA
J Clin Invest; 1973 Dec; 52(12):3064-73. PubMed ID: 4201499
[TBL] [Abstract][Full Text] [Related]
17. Immune status of untreated patients with Hodgkin's disease and prognosis.
Björkholm M; Wedelin C; Holm G; Ogenstad S; Johansson B; Mellstedt H
Cancer Treat Rep; 1982 Apr; 66(4):701-9. PubMed ID: 7074640
[TBL] [Abstract][Full Text] [Related]
18. [Long term effects of splenectomy on the immune-status of Hodgkin's disease patients depending on the modality of treatment (author's transl)].
Schaadt M; Diehl V; Kalden JR; Schmidt N; Laskewitz E
Med Klin; 1978 Oct; 73(40):1381-8. PubMed ID: 309061
[TBL] [Abstract][Full Text] [Related]
19. Ecotaxis: the principle and its application to the study of Hodgkin's disease.
Sousa MD; Yang M; Lopes-Corrales E; Tan C; Hansen JA; Dupont B; Good RA
Clin Exp Immunol; 1977 Jan; 27(1):143-51. PubMed ID: 300302
[TBL] [Abstract][Full Text] [Related]
20. Delayed cutaneous hypersensitivity and blood lymphocyte count in advanced Hodgkin's and non-Hodgkin's lymphomas.
Gupta S; Seth SK; Udupa KN; Sen PC; Rastogi BL
Ann Chir Gynaecol; 1980; 69(2):79-83. PubMed ID: 7377739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]